Global synthetic drugs assessment

Amphetamine-type stimulants and new psychoactive substances

image of Global synthetic drugs assessment
The 2014 Global Synthetic Drugs Assessment provides a global and regional analysis of the synthetic drugs market which includes both Amphetamine-Type Stimulants (ATS) and New Psychoactive Substances (NPS). An increase in methamphetamine trafficking has been observed in many regions and a growing range of NPS has become more widely available globally. This report aims to provide an improved understanding of the problem based on scientific evidence and information provided by Member States.



East and South-East Asia, Oceania and the Pacific

Methamphetamine continues to dominate the ATS market in East and South-East Asia, Oceania and the Pacific. ATS seizures in the region have annually increased from about 13 tons in 2008 to just under 40 tons in 2012. The rapid rise of ATS seizures over the years is primarily attributable to the increase of methamphetamine seizures which about tripled from less than 12 tons in 2008 to 36 tons in 2012. Having increased from about 0.1 tons in 2008 to 2.3 tons in 2011, amphetamine seizures in the region have dropped again to less than 0.2 tons in 2012. Seizures of "ecstasy" have also fluctuated over the years, but have more than tripled in 2012 to 1.9 tons. However, both amphetamine and “ecstasy” seizures in the region have remained at relatively low levels, whilst methamphetamine seizures have annually made up more than 90 per cent of total ATS seizures for a number of years.


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error